Contact
searchSearch
HMP Global
Michael B. FIrst, MD.
Q&As
What Clinicians Need to Know About the DSM-5-TR Updates
07/19/2022
Michael B. First, MD, professor of clinical psychiatry, editor & co-chair, DSM-5-TR, answers questions key changes to the "Introduction" and "Use" sections, explains new diagnoses that have been incorporated, and offers insights on how the...
Michael B. First, MD, professor of clinical psychiatry, editor & co-chair, DSM-5-TR, answers questions key changes to the "Introduction" and "Use" sections, explains new diagnoses that have been incorporated, and offers insights on how the...
Michael B. First, MD, professor...
07/19/2022
Psych Congress Network
Jonathan Meyer
Videos
How to Talk With Patients About LAIs Early on in Schizophrenia Treatment Plan
07/18/2022
Jonathan Meyer, MD
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
Jonathan Meyer
Videos
How to Talk With Patients About LAIs Early on in Schizophrenia Treatment Plan
07/18/2022
Jonathan Meyer, MD
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
From Psych Congress Network
Jonathan Meyer
Videos
How to Talk With Patients About LAIs Early on in Schizophrenia Treatment Plan
07/18/2022
Jonathan Meyer, MD
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
From Psych Congress Network
quiz
Quiz
Anosognosia in Schizophrenia: Coping Strategy or Symptom?
07/11/2022
According to Xavier Amador, PhD, anosognosia in schizophrenia is the neurocognitive symptom of unawareness of being ill. Additionally, according to the DSM-5-TR, anosognosia is what? Take the quiz to find out.
According to Xavier Amador, PhD, anosognosia in schizophrenia is the neurocognitive symptom of unawareness of being ill. Additionally, according to the DSM-5-TR, anosognosia is what? Take the quiz to find out.
According to Xavier Amador, PhD,...
07/11/2022
Psych Congress Network
News
Cognitive Improvement Helps Drive Function Gains in Patients With Schizophrenia
07/05/2022
Jolynn Tumolo
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially...
07/05/2022
Psych Congress Network
News
Chronic PTSD, Comorbid Depression Symptoms Improved With Ketamine
06/16/2022
Jolynn Tumolo
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in post-traumatic stress disorder (PTSD) symptoms compared with a psychoactive placebo in individuals with chronic PTSD.
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in post-traumatic stress disorder (PTSD) symptoms compared with a psychoactive placebo in individuals with chronic PTSD.
Repeated ketamine infusions over...
06/16/2022
Psych Congress Network
News
Cortical Thinning May Begin After Psychosis Onset in Patients With Schizophrenia
06/16/2022
Jolynn Tumolo
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia,...
06/16/2022
Psych Congress Network
Rauch and Amador
Videos
DSM-5 Revisions, Educating Clinicians About Anosognosia
06/13/2022
Lindsay Galvin Rauch and Xavier Amador, PhD, tackle the importance of the DSM-5 revisions on helping to educate clinicians on diagnosing and treating patients with anosognosia.
Lindsay Galvin Rauch and Xavier Amador, PhD, tackle the importance of the DSM-5 revisions on helping to educate clinicians on diagnosing and treating patients with anosognosia.
Lindsay Galvin Rauch and Xavier...
06/13/2022
Psych Congress Network
Rauch and Amador
Videos
The Importance of Collaborative Care in Anosognosia Treatment
06/08/2022
Lindsay Galvin Rauch and Xavier Amador, PhD, address how to incorporate the LEAP (Listen-Emphasize-Agree-Partner) approach in collaborative care as a way to improve relationships.
Lindsay Galvin Rauch and Xavier Amador, PhD, address how to incorporate the LEAP (Listen-Emphasize-Agree-Partner) approach in collaborative care as a way to improve relationships.
Lindsay Galvin Rauch and Xavier...
06/08/2022
Psych Congress Network

Videos

Jonathan Meyer
Videos
How to Talk With Patients About LAIs Early on in Schizophrenia Treatment Plan
07/18/2022
Jonathan Meyer, MD
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
Jonathan Meyer
Videos
How to Talk With Patients About LAIs Early on in Schizophrenia Treatment Plan
07/18/2022
Jonathan Meyer, MD
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
Jonathan Meyer
Videos
How to Talk With Patients About LAIs Early on in Schizophrenia Treatment Plan
07/18/2022
Jonathan Meyer, MD
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
Rauch and Amador
Videos
DSM-5 Revisions, Educating Clinicians About Anosognosia
06/13/2022
Lindsay Galvin Rauch and Xavier Amador, PhD, tackle the importance of the DSM-5 revisions on helping to educate clinicians on diagnosing and treating patients with anosognosia.
Lindsay Galvin Rauch and Xavier Amador, PhD, tackle the importance of the DSM-5 revisions on helping to educate clinicians on diagnosing and treating patients with anosognosia.
Lindsay Galvin Rauch and Xavier...
06/13/2022
Psych Congress Network
Rauch and Amador
Videos
The Importance of Collaborative Care in Anosognosia Treatment
06/08/2022
Lindsay Galvin Rauch and Xavier Amador, PhD, address how to incorporate the LEAP (Listen-Emphasize-Agree-Partner) approach in collaborative care as a way to improve relationships.
Lindsay Galvin Rauch and Xavier Amador, PhD, address how to incorporate the LEAP (Listen-Emphasize-Agree-Partner) approach in collaborative care as a way to improve relationships.
Lindsay Galvin Rauch and Xavier...
06/08/2022
Psych Congress Network
Rauch and Amador
Videos
The Impact of Anosognosia and Noncompliance
05/20/2022
Lindsay Galvin Rauch and Xavier Amador, PhD, discuss how anosognosia impacts treatment noncompliance and the impact on family dynamics.
Lindsay Galvin Rauch and Xavier Amador, PhD, discuss how anosognosia impacts treatment noncompliance and the impact on family dynamics.
Lindsay Galvin Rauch and Xavier...
05/20/2022
Psych Congress Network
Rauch and Amador
Videos
The Impact of Anosognosia and Noncompliance
05/20/2022
Lindsay Galvin Rauch and Xavier Amador, PhD, discuss how anosognosia impacts treatment noncompliance and the impact on family dynamics.
Lindsay Galvin Rauch and Xavier Amador, PhD, discuss how anosognosia impacts treatment noncompliance and the impact on family dynamics.
Lindsay Galvin Rauch and Xavier...
05/20/2022
Psych Congress Network
Dr Leslie Citrome.
Videos
Part 2: Upcoming Schizophrenia Insights at APA Annual Meeting With Dr Citrome
05/17/2022
Leslie Citrome, MD
Leslie Citrome, MD, MPH, shares "what to expect" at this year's American Psychiatric Association 2022 Annual Meeting in the schizophrenia space.
Leslie Citrome, MD, MPH, shares "what to expect" at this year's American Psychiatric Association 2022 Annual Meeting in the schizophrenia space.
Leslie Citrome, MD, MPH, shares...
05/17/2022
Psych Congress Network
Leslie Citrome, MD, MPH
Videos
Upcoming Schizophrenia Insights at APA Annual Meeting With Dr Citrome
05/12/2022
Leslie Citrome, MD
Leslie Citrome, MD, MPH, shares "what to expect" at this year's American Psychiatric Association 2022 Annual Meeting in the schizophrenia space.
Leslie Citrome, MD, MPH, shares "what to expect" at this year's American Psychiatric Association 2022 Annual Meeting in the schizophrenia space.
Leslie Citrome, MD, MPH, shares...
05/12/2022
Psych Congress Network
Rauch and Amador
Videos
Defining and Diagnosing Anosognosia
05/01/2022
Lindsay Galvin Rauch interviews Xavier Amador, PhD, on defining and diagnosing anosognosia as it relates to severe mental illnesses, such as schizophrenia.
Lindsay Galvin Rauch interviews Xavier Amador, PhD, on defining and diagnosing anosognosia as it relates to severe mental illnesses, such as schizophrenia.
Lindsay Galvin Rauch interviews...
05/01/2022
Psych Congress Network

Podcasts

Vlad Maletic, MD, MS
Podcasts
Youth Anxiety During Pandemic and Beyond With Dr Maletic
10/14/2021
Dr Vladimir Maletic evaluates his conversation with Gavin and explains the broader implications for clinicians and caretakers regarding pediatric anxiety during the COVID-19 pandemic and beyond.
Dr Vladimir Maletic evaluates his conversation with Gavin and explains the broader implications for clinicians and caretakers regarding pediatric anxiety during the COVID-19 pandemic and beyond.
Dr Vladimir Maletic evaluates...
10/14/2021
Psych Congress Network
Rick Doblin, PhD
Podcasts
Measuring Cognition in Psychedelic-Assisted Therapy Clinical Trials
09/30/2021
In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, discusses measuring cognition during psychedelic-assisted therapy clinical trials.
In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, discusses measuring cognition during psychedelic-assisted therapy clinical trials.
In his live Table Talk session...
09/30/2021
Psych Congress Network
Rick Doblin, PhD
Podcasts
Measuring Cognition in Psychedelic-Assisted Therapy Clinical Trials
09/30/2021
In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, discusses measuring cognition during psychedelic-assisted therapy clinical trials.
In his live Table Talk session at the Sana Symposium, Rick Doblin, PhD, discusses measuring cognition during psychedelic-assisted therapy clinical trials.
In his live Table Talk session...
09/30/2021
Psych Congress Network
Child in School
Podcasts
A First-Hand Account of Life as a Kid During the Pandemic
09/08/2021
Dr Vladimir Maletic has a conversation with 9-year-old Gavin who explains his daily routine, anxieties, and experiences as a kid living through COVID-19. After, Dr Maletic also shares the broader implications with clinicians.
Dr Vladimir Maletic has a conversation with 9-year-old Gavin who explains his daily routine, anxieties, and experiences as a kid living through COVID-19. After, Dr Maletic also shares the broader implications with clinicians.
Dr Vladimir Maletic has a...
09/08/2021
Psych Congress Network
Child in School
Podcasts
A First-Hand Account of Life as a Kid During the Pandemic
09/08/2021
Dr Vladimir Maletic has a conversation with 9-year-old Gavin who explains his daily routine, anxieties, and experiences as a kid living through COVID-19. After, Dr Maletic also shares the broader implications with clinicians.
Dr Vladimir Maletic has a conversation with 9-year-old Gavin who explains his daily routine, anxieties, and experiences as a kid living through COVID-19. After, Dr Maletic also shares the broader implications with clinicians.
Dr Vladimir Maletic has a...
09/08/2021
Psych Congress Network
Podcasts
Certain Disorders, Education Level Predict High Utilization of Inpatient Psychiatric Services
04/07/2021
Researchers discuss their recent research that found having schizophrenia and dropping out of high school are among the factors that increase the likelihood of high utilization of inpatient psychiatric hospital services.
Researchers discuss their recent research that found having schizophrenia and dropping out of high school are among the factors that increase the likelihood of high utilization of inpatient psychiatric hospital services.
Researchers discuss their recent...
04/07/2021
Psych Congress Network
Podcasts
Developments in Treating Schizophrenia: New Mechanisms of Action and Methods of Delivery
03/18/2021
In this podcast, Schizophrenia Section Editor Leslie Citrome, MD, MPH, reviews recent developments and possible upcoming advances in the treatment of schizophrenia, including new mechanisms of action and methods of delivering medicine.
In this podcast, Schizophrenia Section Editor Leslie Citrome, MD, MPH, reviews recent developments and possible upcoming advances in the treatment of schizophrenia, including new mechanisms of action and methods of delivering medicine.
In this podcast, Schizophrenia...
03/18/2021
Psych Congress Network
Podcasts
Dr. Roger McIntyre Gives a ‘Call to Action’ and the Latest in Bipolar Disorder Management
02/08/2021
In this podcast, Roger McIntyre, MD, FRCPC, discusses his seminar that was written as a "state of the union" address regarding the current state of bipolar disorder (BD) treatment and where it is going in the future.
In this podcast, Roger McIntyre, MD, FRCPC, discusses his seminar that was written as a "state of the union" address regarding the current state of bipolar disorder (BD) treatment and where it is going in the future.
In this podcast, Roger McIntyre,...
02/08/2021
Psych Congress Network

Q&As

Michael B. FIrst, MD.
Q&As
What Clinicians Need to Know About the DSM-5-TR Updates
07/19/2022
Michael B. First, MD, professor of clinical psychiatry, editor & co-chair, DSM-5-TR, answers questions key changes to the "Introduction" and "Use" sections, explains new diagnoses that have been incorporated, and offers insights on how the...
Michael B. First, MD, professor of clinical psychiatry, editor & co-chair, DSM-5-TR, answers questions key changes to the "Introduction" and "Use" sections, explains new diagnoses that have been incorporated, and offers insights on how the...
Michael B. First, MD, professor...
07/19/2022
Psych Congress Network
Q&A
Bipolar Disorder and ADHD Co-Occurrence Rates Indicate Need For Screenings
03/22/2021
The high co-occurrence rates of bipolar disorder (BD) and attention/deficit-hyperactivity disorder (ADHD) indicate clinicians need to routinely carry out screenings for adults with either condition, according to a meta-analysis published...
The high co-occurrence rates of bipolar disorder (BD) and attention/deficit-hyperactivity disorder (ADHD) indicate clinicians need to routinely carry out screenings for adults with either condition, according to a meta-analysis published...
The high co-occurrence rates of...
03/22/2021
Psych Congress Network
Q&A
High Comorbidity Rate of Bipolar Disorder and ADHD “Not by Chance”
03/05/2021
Co-occurrence of adult bipolar disorder (BD) and attention/deficit-hyperactivity disorder (ADHD) is heterogenous and “much higher than expected by chance,” according to a meta-analysis published online in Neuroscience & Biobehavioral Reviews.
Co-occurrence of adult bipolar disorder (BD) and attention/deficit-hyperactivity disorder (ADHD) is heterogenous and “much higher than expected by chance,” according to a meta-analysis published online in Neuroscience & Biobehavioral Reviews.
Co-occurrence of adult bipolar...
03/05/2021
Psych Congress Network
Q&A
Examining How the Pandemic Has Affected the Mental Health of Frontline Workers
02/05/2021
Researchers discuss their finding that health care workers directly involved with the early days of the COVID-19 pandemic experienced mental health problems comparable to those during previous large-scale disasters.
Researchers discuss their finding that health care workers directly involved with the early days of the COVID-19 pandemic experienced mental health problems comparable to those during previous large-scale disasters.
Researchers discuss their...
02/05/2021
Psych Congress Network
Q&A
Detachment From Nature During Pandemic Linked With Depression, Anxiety Symptoms
01/20/2021
Having less access to nature during lockdowns early in the COVID-19 pandemic was associated with reported symptoms of depression and anxiety, researchers reported in the journal Science of the Total Environment.
Having less access to nature during lockdowns early in the COVID-19 pandemic was associated with reported symptoms of depression and anxiety, researchers reported in the journal Science of the Total Environment.
Having less access to nature...
01/20/2021
Psych Congress Network
Q&A
Gender Differences in the Mental Health Effects of the COVID-19 Pandemic
01/17/2021
In this Q&A, Veronica Guadagni, PhD, of the University of Calgary, discusses her research which found that the COVID-19 pandemic has affected women differently than it has affected men.
In this Q&A, Veronica Guadagni, PhD, of the University of Calgary, discusses her research which found that the COVID-19 pandemic has affected women differently than it has affected men.
In this Q&A, Veronica Guadagni,...
01/17/2021
Psych Congress Network
Q&A
Higher Depression Scores Found in Pregnant Women With Exercise Routines Disrupted by Pandemic
01/12/2021
Researchers Theresa Gildner, PhD, MA, and Zaneta Thayer, PhD, explain a newly published study on depression scores in pregnant women whose exercise routines were disrupted by the COVID-19 pandemic.
Researchers Theresa Gildner, PhD, MA, and Zaneta Thayer, PhD, explain a newly published study on depression scores in pregnant women whose exercise routines were disrupted by the COVID-19 pandemic.
Researchers Theresa Gildner,...
01/12/2021
Psych Congress Network
Blog
Is Telepsychiatry Appropriate for Patients With Psychosis?
12/16/2020
Psych Congress Steering Committee member Edward Kaftarian, MD, discusses whether telepsychiatry is appropriate for patients with psychosis.
Psych Congress Steering Committee member Edward Kaftarian, MD, discusses whether telepsychiatry is appropriate for patients with psychosis.
Psych Congress Steering...
12/16/2020
Psych Congress Network

News

News
Cognitive Improvement Helps Drive Function Gains in Patients With Schizophrenia
07/05/2022
Jolynn Tumolo
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially...
07/05/2022
Psych Congress Network
News
Chronic PTSD, Comorbid Depression Symptoms Improved With Ketamine
06/16/2022
Jolynn Tumolo
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in post-traumatic stress disorder (PTSD) symptoms compared with a psychoactive placebo in individuals with chronic PTSD.
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in post-traumatic stress disorder (PTSD) symptoms compared with a psychoactive placebo in individuals with chronic PTSD.
Repeated ketamine infusions over...
06/16/2022
Psych Congress Network
News
Cortical Thinning May Begin After Psychosis Onset in Patients With Schizophrenia
06/16/2022
Jolynn Tumolo
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia,...
06/16/2022
Psych Congress Network
News
Distressing Psychotic-like Experiences in Youth Signal Need for Intervention
12/20/2021
Jolynn Tumolo
Persistent psychotic-like experiences (PLEs) that are distressing are associated with impairment in children in areas including cognitive ability and psychopathology.
Persistent psychotic-like experiences (PLEs) that are distressing are associated with impairment in children in areas including cognitive ability and psychopathology.
Persistent psychotic-like...
12/20/2021
Psych Congress Network
News
Schizophrenia Codes for Nursing Home Patients With Dementia Grew After Antipsychotic Reporting Began
12/01/2021
Jolynn Tumolo
After the implementation of the CMS public reporting of nursing home antipsychotic use, the proportion of residents with different forms of dementia also diagnosed with schizophrenia increased — and more so among patients who were Black...
After the implementation of the CMS public reporting of nursing home antipsychotic use, the proportion of residents with different forms of dementia also diagnosed with schizophrenia increased — and more so among patients who were Black...
After the implementation of the...
12/01/2021
Psych Congress Network
News
Veterans With Schizophrenia Benefit From LAI Therapy
11/16/2021
Jolynn Tumolo
Several long-acting injectable (LAI) antipsychotic medications were associated with a reduced hazard of treatment discontinuation compared with oral olanzapine in US veterans with schizophrenia, according to a study results published in The...
Several long-acting injectable (LAI) antipsychotic medications were associated with a reduced hazard of treatment discontinuation compared with oral olanzapine in US veterans with schizophrenia, according to a study results published in The...
Several long-acting injectable...
11/16/2021
Psych Congress Network
News
Intensive Dietary Intervention Eases Mood Variability in Patients with Bipolar Disorder
10/27/2021
Jolynn Tumolo
New study shows a diet designed to lower omega-6 fatty acid intake and increase omega-3 fatty acid intake improved mood and pain variability in patients with bipolar disorder.
New study shows a diet designed to lower omega-6 fatty acid intake and increase omega-3 fatty acid intake improved mood and pain variability in patients with bipolar disorder.
New study shows a diet designed...
10/27/2021
Psych Congress Network
News
Physically Active Lifestyle Linked with 60% Lower Risk of Anxiety Disorders
10/14/2021
Jolynn Tumolo
Regular exercise is associated with a substantially lower risk of anxiety disorders in both men and women, according to a large population-based study.
Regular exercise is associated with a substantially lower risk of anxiety disorders in both men and women, according to a large population-based study.
Regular exercise is associated...
10/14/2021
Psych Congress Network
News
Mental Health Disorders Contribute to Risk of COVID-19 Mortality
09/03/2021
Erin McGuinness
Patients with mental health disorders are at higher risk for developing severe cases of COVID-19, according to new research published in JAMA Psychiatry.
Patients with mental health disorders are at higher risk for developing severe cases of COVID-19, according to new research published in JAMA Psychiatry.
Patients with mental health...
09/03/2021
Psych Congress Network
News
FDA Approves 6-Month LAI for Treatment of Schizophrenia in Adults
09/01/2021
Heather Flint
Breaking News: The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.
Breaking News: The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.
Breaking News: The US FDA has...
09/01/2021
Psych Congress Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use